Download slides from our Progestogen-only Implant guideline webinar, which took place on 31 March 2021.
Filter documents Clear search
presentation on new assessment in the updated csrh 2021
Brief overview of the Assessment portfolio for the CSRH
Self observation form
The CRSH Curriculum, launched in 2021.
FSRH Scotland Committee Member Specification
We respond to the consultation by The Medicines and Healthcare Products Regulatory Agency (MHRA) on whether to reclassify Lovima, a progestogen-only contraceptive pill, as Pharmacy (P) medicine.
We respond to the consultation by The Medicines and Healthcare Products Regulatory Agency (MHRA) on whether to reclassify Hana, a progestogen-only contraceptive pill, as Pharmacy (P) medicine.
FSRH CEU Guidance: Switching or Starting Methods of Contraception (November 2017, amended March 2021)
Please log into the website to access this document. This quick guide advises on effective starting or switching between contraceptive methods to reduce the risk of unplanned pregnancy. It summarises information from existing FSRH guidance documents. This guide should be used in conjunction with clinical judgment in individual situations. Amended in March 2021.
This summary has been written as a quick reference guide to help busy clinicians to give clear, safe advice on Progestogen-only Implant). Please refer to the full 2018 FSRH Progestogen-only Implant Clinical Guideline for further information and evidence for this advice. This document is written for FSRH members and requires you to log in to access it.